Irbesartan improves arterial compliance more than lisinopril

References

• National High Blood Pressure Education Program Working Group Report on Hypertension in the ElderlyNational High Blood Pressure Education Program Working GroupHypertension1994232752858125550
   PubMed Web of Science ®Google Scholar
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)SHEP Cooperative Research GroupJAMA1991265325532642046107
   PubMed Web of Science ®Google Scholar
• DahlofBHanssonLLindholmLHScherstenBEkbomTWesterPOSwedish Trial in Old Patients with Hypertension (STOP-Hypertension) analyses performed up to 1992Clin Exp Hypertens1993159259397903578
   PubMed Web of Science ®Google Scholar
• HavlikRJLaCroixAZKleinmanJCIngramDDHarrisTCornoni-HuntleyJAntihypertensive drug therapy and survival by treatment status in a national surveyHypertension198913I283122577459
   PubMedGoogle Scholar
• LehmanEDGoslingRGSonksenPHArterial wall compliance in diabetesDiabet Med199291141191563244
   PubMedGoogle Scholar
• LaogunAAGoslinRGIn vivo arterial compliance in manClin Phys Physiol Meas198232012127140158
   PubMedGoogle Scholar
• BenetosALaurentSAsmarRGLacolleyPLarge arterial stiffness in hypertensionJ Hypertens Suppl199715S89979218205
   PubMedGoogle Scholar
• BlacherJAsmarRDjaneSLondonGMSafarMEAortic pulse wave velocity as a marker of cardiovascular risk in hypertensive subjectHypertension1999331111111710334796
   PubMed Web of Science ®Google Scholar
• CameronJDRajkumarCChristophidisNJenningsGLDartAMReduced systemic arterial compliance is associated with left ventricular hypertrophy and diastolic dysfunction in older peopleJ Am Geriatr Soc1997458038089215329
   PubMedGoogle Scholar
• LehmanEDGoslingRGSonksenPHArterial wall compliance in diabetesDiabet Med199291141191563244
   PubMedGoogle Scholar
• GuerinAPBlacherJPannierBMarchaisSJSafarMELondonGMImpact of aortic stiffness attenuation on survival of patients in end-stage renal failureCirculation200110398799211181474
   PubMed Web of Science ®Google Scholar
• BalcherJGuerinAPPannierBImpact of aortic stiffness on survival in End-Stage renal diseaseCirculation1999992434243910318666
   PubMedGoogle Scholar
• CohnJNVascular wall function as a risk marker for cardiovascular diseaseJ Hypertens199917S4144
   Web of Science ®Google Scholar
• GlasserSPArnettDKMcVeighGEFinkelsteinSMBankAJMorganDJVascular compliance and cardiovascular disease: a risk factor or a markerAm J Hypertens199710117511899370391
   PubMed Web of Science ®Google Scholar
• WingLMReidCMRyanPBeilinLJBrownMAJenningsGLSecond Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderlyN Engl J Med200334858359212584366
   PubMed Web of Science ®Google Scholar
• NeutelJMSmithDHWeberMAEffect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular massAm J Hypertens200417374214700510
   PubMed Web of Science ®Google Scholar
• ShargorodskyMLeibovitzELubimovLGavishDZimlichmanRProlonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertensionAm J Hypertens2002151087109112460705
   PubMedGoogle Scholar
• von zur MuhlenBKahanTHaggAMillgardJLindLTreatment with irbesartan or atenolol improves endothelial function in essential hypertensionJ Hypertens2001191813181811593101
   PubMed Web of Science ®Google Scholar
• MahmudAFeelyJFavourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertensionJ Hum Hypertens20001454154610980584
   PubMedGoogle Scholar
• MahmudAFeelyJReduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibitionAm J Hypertens2002151092109512460706
   PubMedGoogle Scholar
• SennSCross-over trials in clinical researchChichesterWiley19936069
   Google Scholar
• AsmarRBenetosATopouchianJLaurentPPannierBBrisacAMAssessment of arterial distensibility by automatic pulse wave velocity measurement: Validation and clinical application studiesHypertension1995264854907649586
   PubMed Web of Science ®Google Scholar
• KnudsenSTAndersenNHPoulsenSHPulse pressure lowering effect of dual blockade with candesartan and lisinopril vs high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALML II study post-hoc analysisAm J Hypertens20082113318268484
   PubMedGoogle Scholar
• KhderYBray-DesboscsLAliotEZannadFEffects of blood pressure control on radial artery diameter and compliance in hypertensive patientsAm J Hypertens1997102692749056683
   PubMedGoogle Scholar
• SlamaMSafavianATualJLLaurentSSafarMEEffects of antihypertensive drugs on large artery complianceNeth J Med1995471622188538819
   PubMedGoogle Scholar
• DahlofBDevereuxRBKjeldsenSELIFE Study GroupCardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLancet2002359995100311937178
   PubMed Web of Science ®Google Scholar
• PittBSegalRMartinezFARandomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)Lancet19973497477529074572
   PubMed Web of Science ®Google Scholar
• PittBPoole-WilsonPASegalREffect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE IILancet20003551582158710821361
   PubMed Web of Science ®Google Scholar
• HornigBLandmesserUKohlerCAhlersmannDSpiekermannSChristophAComparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutaseCirculation200110379980511171786
   PubMed Web of Science ®Google Scholar
• FogariRZoppiAEffects of antihypertensive therapy on sexual activity in hypertensive menCurr Hypertens Rep2002420221012003702
   PubMedGoogle Scholar